A Single Center, Randomized, Open Label, Crossover Study With Ticagrelor and Prasugrel to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Jul 2017
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 18 Jul 2017 Planned End Date changed from 31 Aug 2017 to 31 Oct 2017.
- 18 Jul 2017 Planned primary completion date changed from 31 Jul 2017 to 31 Oct 2017.
- 18 Jul 2017 Planned initiation date changed from 28 Feb 2017 to 28 Aug 2017.